Evidence map›Paper›PMID 28659344›Full record

ArticleThe Journal of biological chemistry2017

Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1.

Can Huang, Maryam Alapa, Ping Shu, Narayani Nagarajan, Changgong Wu, Junichi Sadoshima, Vladyslav Kholodovych, Hong Li, Annie Beuve

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Soluble guanylyl cyclase, the NO receptor, drives vasorelaxation via endothelial S-nitrosation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Redox regulation of soluble guanylyl cyclase.Nitric oxide : biology and chemistry · 2018
    Review
  17. Review
  18. Role of Thioredoxin in Age-Related Hypertension.Current hypertension reports · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Can HuangFrom the Department of Pharmacology, Physiology, and Neuroscience.
Maryam AlapaFrom the Department of Pharmacology, Physiology, and Neuroscience.
Ping ShuFrom the Department of Pharmacology, Physiology, and Neuroscience.
Narayani Nagarajanthe Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey 07103.
Changgong Wuthe Center for Advanced Proteomics Research, Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School Cancer Center, Newark, New Jersey 07103.
Junichi Sadoshimathe Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey 07103.
Vladyslav Kholodovychthe Office of Advanced and Research Computing, Rutgers University, Piscataway, New Jersey 08854, and.
Hong Lithe Center for Advanced Proteomics Research, Department of Microbiology, Biochemistry, and Molecular Genetics, Rutgers New Jersey Medical School Cancer Center, Newark, New Jersey 07103.
Annie BeuveFrom the Department of Pharmacology, Physiology, and Neuroscience, beuveav@njms.rutgers.edu.
Newark Hospital · GBRutgers New Jersey Medical SchoolJohnson University · USRutgers, The State University of New Jersey · US

Funding

Regulation of Soluble Guanylyl Cyclase, the NO-ReceptorR01GM067640 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BEUVE, ANNIE V · 2003 to 2021
$5.8M
NO signaling by a Soluble Guanylyl Cyclase-Thioredoxin transnitrosation complexR01GM112415 · NIGMS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI BEUVE, ANNIE V · 2015 to 2023
$3.5M
NIGMS NIH HHS R01 GM067640NIGMS NIH HHS R01 GM112415
6 · The paper itself

Abstract

Nitric oxide (NO) modulates many physiological events through production of cGMP from its receptor, the NO-sensitive guanylyl cyclase (GC1). NO also appears to function in a cGMP-independent manner, via

Indexed as

Models, MolecularAmino Acid SubstitutionAnimalsAnimals, NewbornCatalytic DomainCells, CulturedChlorocebus aethiopsCOS CellsCysteineGasotransmittersMolecular Docking SimulationMolecular Dynamics SimulationMutationMyocytes, CardiacNitric OxideOxidation-ReductionCysteineGasotransmittersNitric OxideProtein SubunitsRecombinant Fusion ProteinsRecombinant ProteinsSoluble Guanylyl CyclaseThioredoxinsTxn1 protein, ratcyclic GMP (cGMP)guanylate cyclase (guanylyl cyclase)nitric oxideoxidation-reduction (redox)S-nitrosylationthioredoxin

Identifiers

PMID28659344
PMCPMC5582831
OpenAlexW2732331585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.